复发性甲状腺癌的临床试验
总计57151个结果
-
Radboud University Medical CenterMaastricht University Medical Center; Erasmus Medical Center; Catharina Ziekenhuis Eindhoven; Haukeland... 和其他合作者招聘中
-
National Health Research Institutes, Taiwan招聘中
-
Medical University of BialystokMedical Research Agency, Poland尚未招聘
-
Olivia Newton-John Cancer Research InstituteThe Alfred; Austin Health; Peter MacCallum Cancer Centre, Australia; Royal Brisbane and Women's... 和其他合作者招聘中
-
Johns Hopkins UniversityM.D. Anderson Cancer Center; Genzyme, a Sanofi Company; Gustave Roussy, Cancer Campus, Grand Paris完全的
-
Medstar Health Research Institute终止
-
Assistance Publique Hopitaux De Marseille未知
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)终止
-
Ignacio Puche SanzHospital Universitario Reina Sofia de Cordoba招聘中
-
Yonsei University撤销
-
National Cheng-Kung University HospitalKaohsiung Medical University; Kaohsiung Veterans General Hospital.; Chi Mei Medical Hospital招聘中
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company完全的
-
Fifth Affiliated Hospital, Sun Yat-Sen University招聘中
-
Genzyme, a Sanofi Company主动,不招人甲状腺髓样癌 | 局部晚期或转移性甲状腺髓样癌澳大利亚, 奥地利, 比利时, 巴西, 保加利亚, 加拿大, 中国, 捷克语, 丹麦, 芬兰, 德国, 希腊, 印度, 以色列, 意大利, 大韩民国, 波兰, 俄罗斯联邦, 瑞典, 英国